Dojo Surgery
ActiveSummary
Dojo Surgery has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €58k and a net result of €57k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 36% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
86
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency70▲+5
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity tight (current ratio 1.5 against 1.47 in 2024; short-term debt: 51.6% and cash: 44.3% of total assets), and 54.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
45.4%
Return on assets
44.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
58 d early
2024
36 d early
2023
28 d early
2022
17 d early
2021
27 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€58k▼ 36.2%
2024 · €91k
2021: €17k
2022: €78k
2023: €203k
2024: €91k
2021 → 2025
Total assets
€128k▼ 43.7%
2024 · €227k
2021: €31k
2022: €104k
2023: €270k
2024: €227k
2021 → 2025
Net result
€57k▼ 36.6%
2024 · €90k
2021: €17k
2022: €61k
2023: €125k
2024: €90k
2021 → 2025
Working capital
€33k▼ 46.3%
2024 · €61k
2021: €5k
2022: €48k
2023: €161k
2024: €61k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€17k-€78k▲ 367%€203k▲ 160%€91k▼ 55.2%€58k▼ 36.2%
Operating result€21k-€77k▲ 273%€164k▲ 112%€129k▼ 21.3%€85k▼ 34.0%
Net result€17k-€61k▲ 271%€125k▲ 104%€90k▼ 28.0%€57k▼ 36.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 34% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €128k
Fixed assets
€29k ▼ 18.2%
Current assets
€99k ▼ 48.5%
Equity and liabilities €128k
Equity
€58k ▼ 36.2%
Debt
€70k ▼ 48.7%
Debt's share of the balance-sheet total falls from 59.9% to 54.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
€92k▼
2024 · €136k
Cash flow
€64k▼
2024 · €97k
Current ratio
1.50▲
2024 · 1.47
Debt to equity
1.20▼
2024 · 1.49
ROE
98.3%▼
2024 · 98.9%
ROA
44.7%▲
2024 · 39.7%
Interest coverage
12.71▼
2024 · 15.76
Debt ≤ 1 year
€66k▼
2024 · €131k
Income taxes
€21k▼
2024 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€227k€128k▼
Fixed assets21/28€36k€29k▼
Intangible fixed assets21€2k€702▼
Tangible fixed assets22/27€34k€28k▼
Plant, machinery and equipment23€1k€444▼
Furniture and vehicles24€3k€1k▼
Other tangible fixed assets26€31k€27k▼
Current assets29/58€191k€99k▼
Amounts receivable within one year40/41€22k€1k▼
Trade receivables40€14k€1k▼
Other amounts receivable41€8k-
Cash at bank and in hand54/58€125k€57k▼
Deferred charges and accrued income490/1€44k€41k▼
Equity and liabilities
Total equity and liabilities10/49€227k€128k▼
Equity10/15€91k€58k▼
Contributions10/11€1k€1k=
Reserves13€90k€57k▼
Distributable reserves133€90k€57k▼
Amounts payable17/49€136k€70k▼
Amounts payable within one year42/48€131k€66k▼
Trade debts44€2k€2k▼
Suppliers440/4€2k€2k▼
Taxes, remuneration and social security45€45k€15k▼
Taxes450/3€45k€15k▼
Other amounts payable47/48€83k€50k▼
Accrued charges and deferred income492/3€5k€4k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€6k▼
Other operating charges640/8€220€165▼
Gross operating margin9900€136k€92k▼
Operating profit (loss)9901€129k€85k▼
Financial income75/76B€2k€178▼
Recurring financial income75€2k€178▼
Financial charges65/66B€9k€7k▼
Recurring financial charges65€9k€7k▼
Profit (loss) for the period before taxes9903€123k€78k▼
Income taxes67/77€33k€21k▼
Profit (loss) for the period9904€90k€57k▼
Profit (loss) for the period to be appropriated9905€90k€57k▼
Appropriation of the result
Profit (loss) to be appropriated9906€90k€57k▼
Transfer from equity791/2€202k€90k▼
Transfer to equity691/2€90k€57k▼
To other reserves6921€90k€57k▼
Profit to be distributed694/7€202k€90k▼
Return on contributions (dividend)694€202k€90k▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2021net €125k ▲104%
Operating result €164k, net result €125k, both a record.
31-12
Financial
Equity above €200kEq €203k ▲160%
3 profitable years in a row build equity to €203k.
14-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity doublescurrent ratio 2.83
Current ratio from 1.32 to 2.83.
04-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jabbeke · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Varsenareweg 278490 JabbekeGround area
15.2 ha
Building footprint
191 m²
Volume, LiDAR
679 m³
2 parcels, Flanders · tallest building 10.9 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dojo Surgery
since 20212.320.409.353
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31012B0371/00V004 | Flanders | 15.1 ha | 1 · 74 m² | 7.3 m · 1 fl. |
| 31012B0735/00C000 | Flanders | 617 m² | 1 · 116 m² | 10.9 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. M.R. TROMP
BE 0770.537.019
Sint-Gillis-Waas · Eq €57,991
MEERSSEMAN PAULIEN DR.
BE 0773.478.097
Ieper · Eq €58,250
SB Gynécho
BE 0896.706.503
Beauvechain · Eq €57,839
MG Plastic & Surgery
BE 1029.113.679
Boussu · Eq €58,332
DR. VLEESCHOUWERS SABIEN
BE 0766.538.639
Leuven · Eq €58,335
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,336 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-06-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.